Skip to main content
UniHealth

Doctor search

Claudine Bae, NP

Nurse Practitioner · Stanford

NPI 1437687837

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Office
1

Offices

1 location · Stanford Health Care · 3,152 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Claudine Bae’s office at (650) 723-4000 to ask if they take your plan before you enroll.

Hospitals they work in

2 hospitals

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
    Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
  • Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend it
    Overall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths5.31 (4.24 to 6.37) · 8,661 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits14.1 (12.7 to 15.7) · 2,191 casesWorseJan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths4.08 (1.95 to 6.21) · 5,296 casesBetterJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.317BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.446BetterOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0.241BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.6 to 0.9) · 3,348 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.06 (0.45 to 1.67) · 5,374 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.86 (0.72 to 1)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths166.09 (137.88 to 194.3) · 470 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.1 · 192 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths6.4 · 146 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths9.7 · 253 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.3 · 880 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 935 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths8.7 · 501 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.1 · 7,730 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.13 (0 to 0.27) · 20,799 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.28 (0.14 to 0.43) · 23,182 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.94 (0.2 to 1.68) · 5,694 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.36 (1.54 to 3.19) · 7,846 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.2 (3.76 to 6.64) · 5,603 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.38 (0.23 to 2.53) · 2,211 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.52 (0.21 to 0.83) · 19,915 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths3.6 · 416 casesNoneApr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.869No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections0.857No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.368No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16.2 · 247 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.5 · 1,021 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits47.8 · 258 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-1.6 · 990 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits20.8 · 976 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.5 · 959 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.2 (4.4 to 6.2) · 2,191 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.1 · 425 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits9.6 · 158 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.6 · 183 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.7 (10.4 to 15.4) · 4,578 casesNo differentJan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Patient survey stars by topic at Stanford Health Care
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at Stanford Health Care
Room was "always" clean75%
Nurses "always" communicated well82%
Doctors "always" communicated well81%
Staff "always" explained63%
Yes, staff "did" give patients this information89%
Yes, staff "did" give patients information about help after discharge89%
Doctors "always" explained things so they could understand76%
Doctors "always" listened carefully80%
Doctors "always" treated them with courtesy and respect87%
Patients who gave a rating of "9" or "10" (high)79%
Staff "always" explained new medications76%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully79%
Nurses "always" treated them with courtesy and respect88%
"Always" quiet at night53%
"YES", patients would definitely recommend the hospital83%
Staff "always" explained possible side effects50%
Yes, staff "did" give patients information about possible symptoms90%
See every measure and the patient survey for Stanford Health Care Tri-Valley

Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at Stanford Health Care Tri-Valley
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.178BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.237BetterOct 2024 – Sep 2025
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.79 (0 to 1.73) · 1,041 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.79 (0.5 to 1.08)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths145.81 (96.5 to 195.12) · 72 casesNo differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths2.9 · 55 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths8.6 · 92 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12.5 · 96 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths9.5 · 395 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 391 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.1 · 162 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3 · 1,736 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.16 (0 to 0.37) · 4,425 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.22 (0.02 to 0.41) · 4,771 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.45 (1.46 to 5.44) · 1,403 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.5 (0.05 to 2.94) · 645 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths1.81 (0.38 to 3.24) · 1,279 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths8.53 (3.2 to 13.85) · 639 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5.15 (1.89 to 8.41) · 648 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.61 (0.14 to 3.07) · 370 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.16 (0 to 0.83) · 4,160 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 74 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.369No differentOct 2024 – Sep 2025
MRSA BacteremiaInfections1.112No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections0No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits13.1 · 110 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20.1 · 437 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits-5.8 · 94 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-19.3 · 456 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits-0.3 · 402 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits15.8 · 358 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits6.8 (4.7 to 9.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits10.1 (7.5 to 13.6) · 198 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 80 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.9 · 46 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits19.3 · 92 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits12.4 (9.6 to 16.2) · 1,532 casesNo differentJan 2022 – Dec 2024
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits1 (0.8 to 1.2) · 929 casesNo differentJan 2024 – Dec 2024

What patients said (1,268 patients answered, 26% of those asked)

Patient survey stars by topic at Stanford Health Care Tri-Valley
Cleanliness3
Nurse communication3
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating3
Quietness2
Recommend hospital4
Share of patients giving the best answer at Stanford Health Care Tri-Valley
Room was "always" clean65%
Nurses "always" communicated well77%
Doctors "always" communicated well79%
Staff "always" explained58%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge88%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)70%
Staff "always" explained new medications72%
Nurses "always" explained things so they could understand73%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect84%
"Always" quiet at night42%
"YES", patients would definitely recommend the hospital74%
Staff "always" explained possible side effects44%
Yes, staff "did" give patients information about possible symptoms89%

Original Medicare doctor bills

$34,311

Medicare paid this office $34,311 for 196 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Return visit (30+ min)96$13,713$95
Long return visit (40+ min)42$9,114$136
Long return visit (40+ min)30$5,540$111
Return visit (30+ min)63$5,106$71

Who their Medicare patients are

196 Original Medicare patients in 2024. Average age 72 · Also on Medicaid 32% · Health risk score 1.77. Above the middle of the specialty; the typical nurse practitioner clinician is at 1.42.

Conditions among them: High blood pressure 70% · Cancer 54% · Diabetes 24% · Chronic kidney disease 18% · Coronary heart disease 17% · Atrial fibrillation 16% · Depression 16% · Heart failure 13% · COPD 8%.

The office billed $160,496, Medicare allowed $44,054 and paid $34,311; for 357 services of 9 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024196357721.77$160,496$34,311
202344718762.10$65,993$23,838
202250368741.67$46,359$14,556
202184178711.16$30,241$11,906
202078131701.37$33,143$8,724
20192561,818671.45$353,624$52,709
20182431,048661.45$246,678$38,908
201790246651.46$53,216$9,511

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 11 services

Original Medicare services billed in 2023
Return visit (30+ min)33$4,944$77
New patient visit (45+ min)14$1,309$94
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count36$601$8
Blood test, comprehensive group of blood chemicals27$435$10
Insertion of needle into vein for collection of blood sample25$416$8
Ferritin (blood protein) level13$214$13
Cyanocobalamin (vitamin b-12) level14$207$15
Transferrin (iron binding protein) level13$200$13
Folic acid level, serum12$173$14
Iron level13$101$6
Lactate dehydrogenase (enzyme) level14$89$6

2022: 8 services

Original Medicare services billed in 2022
Return visit (30+ min)21$2,588$89
Long return visit (40+ min)14$1,485$99
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count25$313$8
Blood test, comprehensive group of blood chemicals19$249$10
Ferritin (blood protein) level12$201$13
Transferrin (iron binding protein) level12$188$13
Insertion of needle into vein for collection of blood sample26$104$3
Iron level12$96$6

2021: 4 services

Original Medicare services billed in 2021
Long return visit (40+ min)68$8,255$120
Short return visit47$1,788$38
Return visit (30+ min)13$1,101$85
Insertion of needle into vein for collection of blood sample41$120$3

2020: 3 services

Original Medicare services billed in 2020
Long return visit (40+ min)57$5,440$94
Return visit (30+ min)40$2,724$68
Short return visit (20+ min)16$209$13

2019: 7 services

Original Medicare services billed in 2019
Short return visit (20+ min)238$34,418$43
Testing for presence of drug, by chemistry analyzers116$12,672$63
New patient visit (30+ min)32$2,209$69
Aspiration and/or injection of fluid from large joint13$1,009$37
Injection of drug or substance under skin or into muscle41$803$10
Injection, ketorolac tromethamine, per 15 mg31$59None
Injection, dexamethasone sodium phosphate, 1 mg35$42None

2018: 6 services

Original Medicare services billed in 2018
Short return visit (20+ min)230$28,491$46
Testing for presence of drug, by chemistry analyzers63$5,209$69
New patient visit (30+ min)21$1,453$69
Injection of drug or substance under skin or into muscle20$506$14
Injection, ketorolac tromethamine, per 15 mg17$40None
Injection, dexamethasone sodium phosphate, 1 mg14$13None

2017: 2 services

Original Medicare services billed in 2017
Short return visit (20+ min)82$6,363$50
Testing for presence of drug, by chemistry analyzers12$939$78

Medicaid work

$77,116 in 2019

Medicaid paid $77,116 for 3,297 billed services this clinician did in 2019, up to 174 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2019
Short return visit (20+ min)1,916$65,719
Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service616$7,286
New patient visit (30+ min)59$2,499
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular106$1,442
Injection, dexamethasone sodium phosphate, 1 mg46$90
Injection, ketorolac tromethamine, per 15 mg57$80
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications211$0
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented286$0
Medicaid work by year
20193,2978174$77,116
20181,372481$43,707
See the largest Medicaid services in earlier years

2018

Largest Medicaid services in 2018
Short return visit (20+ min)1,179$41,512
Drug test(s), presumptive, any number of drug classes, any number of devices or procedures; by instrument chemistry analyzers (eg, utilizing immunoassay [eg, EIA, ELISA, EMIT, FPIA, IA, KIMS, RIA]), chromatography (eg, GC, HPLC), and mass spectrometry either with or without chromatography, (eg, DART, DESI, GC-MS, GC-MS/MS, LC-MS, LC-MS/MS, LDTD, MALDI, TOF) includes sample validation when performed, per date of service71$2,195
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications61$0
Pain assessment documented as positive using a standardized tool and a follow-up plan is documented61$0

Drugs they prescribed that Part D paid

$648,469

Pharmacies billed $648,469 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 3% of their Part D prescriptions (13 of 388) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.

295 generic and 93 brand-name prescriptions · $648,469 in drug cost · 20 antibiotic prescriptions to 15 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lynparza25$358,967$14,359
Eliquis36$31,698$880
Xarelto12$6,594$550
Hydroxyurea39$1,083$28
Ondansetron52$941$18
See all 9 drugs
Every Part D drug this clinician prescribed
Lynparza25$358,967$14,359
Eliquis36$31,698$880
Xarelto12$6,594$550
Hydroxyurea39$1,083$28
Ondansetron52$941$18
Gabapentin15$725$48
Prochlorperazine Maleate25$256$10
Anastrozole18$209$12
Amlodipine Besylate13$19$1

Year by year

Part D prescribing by year
20243881443% (13)24%$648,469
20234151295% (21)17%$71,995
2022215836% (12)19%$174,853
20201588020% (31)None$4,827
20193,05560856% (1,697)4%$117,913
20183,32969955% (1,836)5%$111,532
20171,05630963% (667)5%$36,425

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 11 drugs

Part D drugs prescribed in 2023
Eliquis39$33,177$851
Xarelto12$9,255$771
Hydroxyurea66$2,445$37
Anastrozole35$620$18
Prochlorperazine Maleate26$456$18
Omeprazole11$286$26
Warfarin41$280$7
Levothyroxine16$206$13
Hydrocodone-Acetaminophen12$181$15
Prednisone19$87$5
Baclofen11$67$6

2022: 5 drugs

Part D drugs prescribed in 2022
Eliquis16$9,081$568
Prochlorperazine Maleate32$908$28
Hydroxyurea21$772$37
Anastrozole14$317$23
Prednisone11$95$9

2020: 3 drugs

Part D drugs prescribed in 2020
Gabapentin39$1,084$28
Baclofen15$331$22
Nortriptyline13$103$8

2019: 27 drugs

Part D drugs prescribed in 2019
Lyrica31$17,891$577
Hydrocodone-Acetaminophen612$13,973$23
Oxycodone-Acetaminophen347$12,054$35
Gabapentin516$10,906$21
Oxycontin13$7,954$612
Oxycodone315$6,910$22
Morphine Sulfate Er139$3,415$25
Tizanidine131$3,329$25
Diclofenac39$2,648$68
Baclofen130$2,557$20
Pregabalin22$2,020$92
Morphine Sulfate46$1,484$32
Nortriptyline114$1,212$11
Fentanyl16$1,146$72
Zonisamide42$1,142$27
Tramadol113$997$9
Ibuprofen55$722$13
Cyclobenzaprine59$688$12
Amitriptyline31$631$20
Methadone56$627$11
Duloxetine15$536$36
Ibu31$358$12
Meloxicam44$264$6
Hydromorphone16$221$14
Methocarbamol14$140$10
Carisoprodol13$85$7
Acetaminophen-Codeine12$80$7

2018: 30 drugs

Part D drugs prescribed in 2018
Lyrica36$17,465$485
Hydrocodone-Acetaminophen563$14,146$25
Oxycodone-Acetaminophen386$13,594$35
Gabapentin566$13,134$23
Oxycodone296$6,788$23
Morphine Sulfate Er179$5,667$32
Savella11$3,829$348
Voltaren14$3,031$217
Tizanidine131$2,884$22
Lidocaine11$2,446$222
Baclofen128$2,435$19
Morphine Sulfate60$2,159$36
Nortriptyline179$2,132$12
Diclofenac20$1,869$93
Duloxetine39$1,716$44
Methadone127$1,698$13
Zonisamide48$1,431$30
Fentanyl20$1,421$71
Tramadol129$1,264$10
Celecoxib13$947$73
Cyclobenzaprine40$705$18
Hydromorphone36$432$12
Ibu37$418$11
Meloxicam44$359$8
Ibuprofen23$275$12
Acetaminophen-Codeine22$269$12
Naproxen21$138$7
Carisoprodol17$116$7
Zolpidem14$97$7
Clonidine11$61$6

2017: 19 drugs

Part D drugs prescribed in 2017
Oxycodone-Acetaminophen150$6,044$40
Lyrica11$5,383$489
Morphine Sulfate Er99$3,760$38
Oxycodone128$2,981$23
Hydrocodone-Acetaminophen145$2,363$16
Voltaren12$1,984$165
Gabapentin108$1,728$16
Fentanyl17$1,297$76
Methadone47$734$16
Nortriptyline55$578$11
Baclofen22$541$25
Morphine Sulfate21$504$24
Tizanidine24$475$20
Duloxetine12$329$27
Tramadol35$298$9
Zonisamide17$270$16
Hydromorphone15$172$11
Zolpidem16$105$7
Carisoprodol14$96$7

Money from drug and device companies

$559 in 2025

Industry payments by year
202558None$559
202411None$34
2023916None$515
202269None$492
202112None$39
202011None$27
201912None$33

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
AstraZeneca Pharmaceuticals LPNone$132
1 payment
  • Meals · 2025-07-16 · $132
Inspire Medical SystemsInspire$130
1 payment
  • Meals for Inspire · 2025-06-18 · $130
Amarin PharmaVascepa$118
1 payment
  • Meals for Vascepa · 2025-03-14 · $118
Argenx USVyvgart$90
1 payment
  • Meals for Vyvgart · 2025-04-16 · $90
Merck Sharp & DohmeKeytruda$89
4 payments
  • Meals for Keytruda · 2025-10-17 · $19
  • Meals for Keytruda · 2025-08-22 · $18
  • Meals for Keytruda · 2025-05-16 · $20
  • Meals for Keytruda · 2025-03-28 · $32
See all 8 published payments
Every published payment
Merck Sharp & DohmeMeals · 2025-10-17Keytruda$19
Merck Sharp & DohmeMeals · 2025-08-22Keytruda$18
AstraZeneca Pharmaceuticals LPMeals · 2025-07-16None$132
Inspire Medical SystemsMeals · 2025-06-18Inspire$130
Merck Sharp & DohmeMeals · 2025-05-16Keytruda$20
Argenx USMeals · 2025-04-16Vyvgart$90
Merck Sharp & DohmeMeals · 2025-03-28Keytruda$32
Amarin PharmaMeals · 2025-03-14Vascepa$118
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)

2024: $34

Payments by company in 2024
Merck Sharp & DohmeLynparza$34
1 payment
  • Meals for Lynparza · 2024-12-20 · $34

2023: $515

Payments by company in 2023
AstraZeneca Pharmaceuticals LPImfinzi$129
2 payments
  • Meals for Imfinzi · 2023-08-29 · $122
  • Meals for Tagrisso · 2023-07-18 · $7
Lilly USANone$85
1 payment
  • Meals · 2023-01-18 · $85
GlaxoSmithKlineZejula$75
4 payments
  • Meals for Zejula · 2023-12-21 · $16
  • Meals for Zejula · 2023-11-30 · $17
  • Meals for Zejula · 2023-10-05 · $26
  • Meals for Zejula · 2023-07-20 · $16
Janssen BiotechDarzalex$70
1 payment
  • Education for Darzalex · 2023-11-28 · $70
AbbvieVenclexta$49
2 payments
  • Meals for Venclexta · 2023-12-19 · $20
  • Meals for Venclexta · 2023-03-07 · $28
Boston ScientificWavewriter Alpha Prime 16$46
3 payments
  • Meals for Wavewriter Alpha Prime 16 · 2023-11-02 · $19
  • Meals · 2023-07-12 · $14
  • Meals · 2023-05-10 · $13
Karyopharm TherapeuticsXpovio$24
1 payment
  • Meals for Xpovio · 2023-07-25 · $24
SeagenTukysa$22
1 payment
  • Meals for Tukysa · 2023-11-07 · $22
CelgenePomalyst$15
1 payment
  • Meals for Pomalyst · 2023-05-10 · $15

2022: $492

Payments by company in 2022
Lilly USANone$206
2 payments
  • Education · 2022-08-06 · $118
  • Education · 2022-03-22 · $88
AmgenNone$99
1 payment
  • Education · 2022-05-02 · $99
Karyopharm TherapeuticsXpovio$97
1 payment
  • Meals for Xpovio · 2022-02-16 · $97
Boston ScientificGeneral - Pain Management$43
3 payments
  • Meals for Coveredge 32 · 2022-10-12 · $14
  • Meals for Clinical Trial Product · 2022-07-05 · $12
  • Meals for General - Pain Management · 2022-06-22 · $17
AbbvieVenclexta$32
1 payment
  • Meals for Venclexta · 2022-11-15 · $32
SeagenTukysa$15
1 payment
  • Meals for Tukysa · 2022-04-05 · $15

2021: $39

Payments by company in 2021
Boston ScientificClick$39
2 payments
  • Meals for General Pain Management · 2021-02-26 · $19
  • Meals for Click · 2021-02-22 · $20

2020: $27

Payments by company in 2020
Boston ScientificEntrada$27
1 payment
  • Meals for Entrada · 2020-12-08 · $27

2019: $33

Payments by company in 2019
Boston ScientificSpectra Wavewriter$33
2 payments
  • Meals for Spectra Wavewriter · 2019-08-20 · $14
  • Meals for Spectra Wavewriter · 2019-01-16 · $20

Professional record

NPI
1437687837
Licence
CA 95026504, NV APRN002511
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Medicaid ID
NV 1437687837
Taxonomy
Nurse practitioner (363L00000X); Federal specialty code 170300000X (170300000X); Federal specialty code 363LF0000X (363LF0000X); Federal specialty code 363LX0001X (363LX0001X)
Mailing address
300 Pasteur Dr, Stanford, CA, 94305
NPI first listed
2017-05-30
NPI last updated
2025-12-30
NPI record certified
2025-12-30

This is when the NPI record was last certified, not a medical board exam.

Extra NPI addresses: 8285 W Arby Ave Ste 100-B, Las Vegas, NV, 89113